Volume 22, Issue 4 - Good Pharma

India as a hub for ethical and evidence-based medical communications

Author: Chandrima Pal

Abstract

Download the full article

References

1. Pharma Emerging Markets 2.0. How emerging markets are driving the transformation of the pharmaceutical industry. Booz & Company Inc; 2013. [cited 2013 Aug 12]. Available from: http://www.booz.com/media/file/BoozCo_Pharma-Emerging-Markets-2.0.pdf
2. The global use of medicines: outlook through 2016, Report by the IMS Institute for Healthcare Informatics. 2012. [cited 2013 Aug 12] Available from: http://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/Global%20Use%20of%20Meds%202011/Medicines_Outlook_Through_2016_Report.pdf
3. Guidance for industry: responding to unsolicited requests for off-label information about prescription drugs and medical devices. 2011 [cited 2013 Aug 12]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM285145.pdf
4. . Keary E, Byrne M, Lawton A. How to conduct a literature review? Irish Psychol 2012;38(9–10):239–45.
5. Basrur R. Medical writing in India. Write Stuff 2006;15(2):50–1.
6. Pal C. It is a critical issue, the topic of outsourcing: Commentary on ‘What price quality?’ Write Stuff 2011;20(2):96–7.
7. Bose S. Medical writing in India at a crossroads. Medical Writing 2013;22(2):94–5.
8. Das N, Das S. The changing face of medical writing in India. Medical Writing 2013;22(2):91–3.
9. Samulack D, D'Souza E. Medical writing outside the US: challenges and opportunities – the Indian perspective. Presented at the 68th Annual Conference of the American Medical Writers Association; 2008 October 25; Louisville, KY. 2008 [cited 2013 Feb 12] Available from: http://www.cactusmed.com/files/amwa-presentation-68th-anualconference.pdf
10. Pal C. From researcher in Europe to medical writer in India. Medical Writing 2012;21(1):39–41.